Holen Sie sich die Stockscreener-App
35.34
1.37%
-0.515
Schlusskurs vom Vortag:
$35.85
Offen:
$35.51
24-Stunden-Volumen:
150.91K
Relative Volume:
0.13
Marktkapitalisierung:
$2.06B
Einnahmen:
$277.49M
Nettoeinkommen (Verlust:
$-192.14M
KGV:
-10.52
EPS:
-3.36
Netto-Cashflow:
$-95.52M
1W Leistung:
-1.48%
1M Leistung:
+25.12%
6M Leistung:
-27.69%
1J Leistung:
-26.07%
1-Tages-Spanne:
$34.85
$35.73
1-Wochen-Bereich:
$33.94
$36.35
52-Wochen-Spanne:
$27.12
$60.90
Twist Bioscience Corp Stock (TWST) Company Profile
Firmenname
Twist Bioscience Corp
Sektor
Branche
Telefon
800-719-0671
Adresse
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Vergleichen Sie TWST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
35.35 | 2.06B | 277.49M | -192.14M | -95.52M | -3.36 |
|
TMO
Thermo Fisher Scientific Inc
|
400.16 | 156.49B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
197.95 | 145.01B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
528.24 | 42.30B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
117.81 | 34.24B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
156.71 | 27.64B | 15.50B | 1.33B | 2.16B | 7.34 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2024-06-04 | Eingeleitet | Guggenheim | Buy |
| 2024-01-17 | Hochstufung | Goldman | Neutral → Buy |
| 2023-09-27 | Eingeleitet | Berenberg | Buy |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-01-03 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-03-02 | Fortgesetzt | Cowen | Outperform |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-29 | Eingeleitet | William Blair | Outperform |
| 2021-06-04 | Eingeleitet | Goldman | Neutral |
| 2021-04-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-02-05 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-01-04 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2020-10-20 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2019-05-31 | Eingeleitet | Evercore ISI | Outperform |
| 2018-11-26 | Eingeleitet | JP Morgan | Neutral |
Alle ansehen
Twist Bioscience Corp Aktie (TWST) Neueste Nachrichten
Here's Why We're Not At All Concerned With Twist Bioscience's (NASDAQ:TWST) Cash Burn Situation - Yahoo Finance
Twist Bioscience Co. (NASDAQ:TWST) Shares Purchased by Handelsbanken Fonder AB - Defense World
Twist Bioscience Co. (NASDAQ:TWST) Shares Acquired by GAMMA Investing LLC - Defense World
Rhumbline Advisers Increases Stock Holdings in Twist Bioscience Co. (NASDAQ:TWST) - Defense World
Twist Bioscience Corp (TWST) Shares Up 4.12% on Jun 11 - GuruFocus
Twist Bioscience Executives Sell Shares for Tax Obligations - TradingView
Twist Bioscience Co. (NASDAQ:TWST) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World
Twist Bioscience Corp (TWST) Stock Price Up 3.86% on Jun 6 - GuruFocus
Twist Bioscience at 45th Annual William Blair Growth Stock Conference: Strategic Advances - Investing.com
Twist Bioscience Corp (TWST) Stock Price Up 5.94% on Jun 2 - GuruFocus
Cetera Investment Advisers Invests $220,000 in Twist Bioscience Co. (NASDAQ:TWST) - Defense World
Twist Bioscience Corp (TWST) Shares Gap Down to $28.2 on May 28 - GuruFocus
Twist Bioscience Co. (NASDAQ:TWST) Stake Raised by Nuveen Asset Management LLC - Defense World
Twist Bioscience Co. (NASDAQ:TWST) Shares Sold by Bank of America Corp DE - Defense World
Twist Bioscience Executives Sell Shares to Cover Tax Obligations - TradingView
Ameriprise Financial Inc. Trims Stake in Twist Bioscience Co. (NASDAQ:TWST) - Defense World
Twist Bioscience Corp (TWST) Shares Down 5.14% on May 21 - GuruFocus
Twist Bioscience (TWST) Expands Partnership with Element Bioscie - GuruFocus
Twist Bioscience (TWST) Expands Partnership with Element Biosciences | TWST Stock News - GuruFocus
Twist Bioscience and Element Biosciences Expand Collaboration to Transform Next Generation Sequencing Workflows with Co-Developed End-to-End Solutions - Business Wire
Twist Bioscience stock hits 52-week low at $28.41 By Investing.com - Investing.com Canada
Twist Bioscience stock hits 52-week low at $28.41 - Investing.com
Twist Bioscience Corp (TWST) Stock Price Down 3.12% on May 19 - GuruFocus
Brokerages Set Twist Bioscience Co. (NASDAQ:TWST) Target Price at $50.40 - Defense World
Twist Bioscience to Present at William Blair 45th Annual Growth Stock Conference - 01net
DNA Synthesis Market to Witness Growth from Synthetic Biology - openPR.com
Stifel Financial Corp Purchases 1,364 Shares of Twist Bioscience Co. (NASDAQ:TWST) - Defense World
Cathie Wood’s ARK adjusts positions, selling Archer Aviation, buying Twist Bioscience - Investing.com Nigeria
Cathie Wood’s ARK adjusts positions, selling Archer Aviation, buying Twist Bioscience By Investing.com - Investing.com South Africa
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire
Leerink Partnrs Cuts Earnings Estimates for Twist Bioscience - Defense World
William Blair Issues Optimistic Outlook for TWST Earnings - Defense World
Billionaire Nicholas J. Pritzker’s 8 Stocks with Huge Upside Potential - Insider Monkey
Twist Bioscience Corporation (TWST): Among Nicholas J. Pritzker’s Stock Picks with Huge Upside Potential - Yahoo Finance
Twist Bioscience and Ginkgo Bioworks update DNA supply deal - Investing.com
Twist Bioscience and Ginkgo Bioworks Revise Collaboration - Business Wire
The Goldman Sachs Group Issues Pessimistic Forecast for Twist Bioscience (NASDAQ:TWST) Stock Price - Defense World
Cathie Wood’s ARK Makes Bold Tuesday Moves with Key Stock Swaps - Wall Street Pit
Twist Bioscience (NASDAQ:TWST) Reaches New 52-Week Low After Earnings Miss - Defense World
Twist Bioscience: Expansion Efforts Continue To Face Challenges (NASDAQ:TWST) - Seeking Alpha
Goldman Sachs Adjusts Price Target for Twist Bioscience (TWST) | - GuruFocus
Where Twist Bioscience Stands With Analysts - Benzinga
Goldman Sachs Adjusts Price Target for Twist Bioscience (TWST) | TWST Stock News - GuruFocus
Guggenheim Reiterates Buy Rating on Twist Bioscience (TWST) with $50 Price Target | TWST Stock News - GuruFocus
Twist Bioscience (TWST) Price Target Lowered by Baird | TWST Sto - GuruFocus
Twist Bioscience (TWST) Price Target Lowered by Baird | TWST Stock News - GuruFocus
JP Morgan Adjusts Price Target for Twist Bioscience (TWST) | TWS - GuruFocus
JP Morgan Adjusts Price Target for Twist Bioscience (TWST) | TWST Stock News - GuruFocus
Twist Bioscience Corporation (NASDAQ:TWST) Q2 2025 Earnings Call Transcript - Insider Monkey
Twist Bioscience (TWST) Price Target Adjusted by Analyst | TWST Stock News - GuruFocus
JPMorgan Adjusts Price Target for Twist Bioscience (TWST) | TWST Stock News - GuruFocus
Finanzdaten der Twist Bioscience Corp-Aktie (TWST)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):